Opening Hours Free Reading Articles 24 Hours

Cannabis

CBD Medical

Cannabis Market Size to Hit $147 Billion by 2027 with Booming CAGR Value of 29.1{b574a629d83ad7698d9c0ca2d3a10ad895e8e51aa97c347fc42e9508f0e4325d}

The Insight Partners Global cannabis market growth is driven by the growing legalization of medical cannabis; increasing medicinal application of cannabis; and rising awareness regarding medical cannabis through conferences, symposia, and workshops. New York, Nov. 16, 2022 (GLOBE NEWSWIRE) — According to The Insight Partners new market research study of…

CBD Medical

GREATER CANNABIS COMPANY, INC. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)

Company Overview From July 2018 through mid-2021, Greater Cannabis focused on commercializing its own and licensed technologies worldwide for transmucosal and transdermal delivery of legal medical or recreational cannabis (other than in the field of oral care) and cannabinoids (“CBD”). While part of the cannabis family, CBD, which contains less…

CBD Medical

Medical Cannabis Market Size to Hit USD 33,210.21 Million

New York, United states of america, Nov. 03, 2022 (World NEWSWIRE) — Professional medical Hashish Current market Overview: In accordance to a Thorough Investigate Report by Sector Analysis Potential (MRFR),  “Health-related Cannabis Sector Information and facts By Solution Kind, By-product, Software, Distribution Channel, and Area – Forecast until 2027, the…

CBD Medical

What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD

Some CBD Merchandise are Being Marketed with Unproven Healthcare Claims and Could be Generated with Unsafe Producing Methods Compared with the Fda-accredited CBD drug merchandise, unapproved CBD products and solutions, which could include cosmetics, foodstuff, products promoted as dietary dietary supplements, and any other product or service (other than Epidiolex) generating…

CBD Medical

Cannaray Limited, a leading European cannabis company, to list its CBD subsidiaries (Cannaray CBD & Love CBD) via public listing. Company will focus on booming medical and recreational cannabis opportunities in Europe through its Medical Cannabis division

Cannaray Minimal, a main European healthcare hashish and wellness CBD company, is right now saying the signing of an special LOI for the listing of its CBD division (Cannaray Manufacturers Ltd and Love CBD Wellness Ltd) through a reverse takeover of Cellular Items PLC (LSE: CBX). The expected complete deal…